Bausch Health Companies
Price & Volume
Stats
See more52W Range | $3.96-$9.85 |
Market Cap | $2.4B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $9.7B |
Revenue Growth (YoY) | 4.9% |
Gross Profit (12 Mos) | $6.8B |
Diluted EPS | -$0.12 |
News
See moreYahoo Finance • 7 days ago
Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel
Yahoo Finance • 12 days ago
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
Yahoo Finance • 23 days ago
Up 40%+ in June ALONE, these stocks are crushing a sideways market
Yahoo Finance • 25 days ago
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
About
CEO | Mr. Thomas J. Appio |
CFO | Mr. Jean-Jacques Charhon |
Address | 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 20,700 |
